• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性低钙血症性高钙血症和原发性甲状旁腺功能亢进症患者的前臂骨矿物质密度:一项对比研究。

Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.

机构信息

Department of Internal Medicine and Endocrinology MEA, Aarhus University Hospital, THG, Denmark.

出版信息

Calcif Tissue Int. 2011 Oct;89(4):285-94. doi: 10.1007/s00223-011-9517-x. Epub 2011 Jul 22.

DOI:10.1007/s00223-011-9517-x
PMID:21785908
Abstract

Studies have shown that cancellous bone is relatively preserved in primary hyperparathyroidism (PHPT), whereas bone loss is seen in cortical bone. Familial hypocalciuric hypercalcemia (FHH) patients seem to preserve bone mineral in spite of hypercalcemia and often elevated plasma parathyroid hormone (PTH). The objective of this study was to compare total and regional forearm bone mineral density (BMD) in patients with PHPT and FHH and to examine if differences can be used to separate the two disorders. We included 63 FHH, and 121 PHPT patients in a cross-sectional study. We performed dual-energy X-ray absorptiometry scans of the forearm, hip and lumbar spine and measured a number of biochemical variables. PTH patients had significantly lower Z-scores in all parts of the forearm compared to FHH. This was also the case after adjustment for body mass index. When stratifying for age, gender and PTH, T-scores were still significantly lower in PHPT patients than in FHH patients at the total, the mid and the ultradistal forearm, but not at the proximal 1/3 forearm. In a multiple regression analysis BMD Z-score was lower in PHPT compared to FHH at the total forearm, the mid forearm and the ultradistal forearm but not the proximal forearm when adjusting for biochemical variables including PTH, 1,25(OH)(2)D and Ca(2+). These observations support that inactivating mutations in the CASR gene in bone cells in FHH may protect against forearm bone loss. Differences between the two groups in total or regional forearm BMD were inferior to the calcium/creatinine clearance ratio as a diagnostic tool to separate FHH from PHPT.

摘要

研究表明,在原发性甲状旁腺功能亢进症(PHPT)中松质骨相对保留,而皮质骨则出现骨丢失。家族性低钙血症性高钙血症(FHH)患者尽管存在高钙血症和常升高的血浆甲状旁腺激素(PTH),但其骨矿物质似乎得以保留。本研究的目的是比较 PHPT 和 FHH 患者的前臂总骨密度(BMD)和区域性 BMD,并探讨这些差异是否可用于区分两种疾病。我们纳入了 63 例 FHH 和 121 例 PHPT 患者进行横断面研究。我们对前臂、髋部和腰椎进行了双能 X 线吸收法扫描,并测量了多项生化变量。与 FHH 相比,PTH 患者的前臂各部位的 Z 评分均显著降低。在对体质指数进行调整后也是如此。当按年龄、性别和 PTH 进行分层时,PHPT 患者的 T 评分在整个前臂、前臂中段和远段仍显著低于 FHH 患者,但在前臂近端 1/3 处则无差异。在多元回归分析中,在校正包括 PTH、1,25(OH)(2)D 和 Ca(2+)在内的生化变量后,PHPT 患者的 BMD Z 评分在整个前臂、前臂中段和远段前臂均低于 FHH,但在前臂近端 1/3 处则无差异。这些观察结果表明,FHH 中骨细胞中的 CASR 基因突变失活可能会防止前臂骨丢失。两组间总前臂或区域性前臂 BMD 的差异不如钙/肌酐清除率比值作为区分 FHH 和 PHPT 的诊断工具。

相似文献

1
Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.家族性低钙血症性高钙血症和原发性甲状旁腺功能亢进症患者的前臂骨矿物质密度:一项对比研究。
Calcif Tissue Int. 2011 Oct;89(4):285-94. doi: 10.1007/s00223-011-9517-x. Epub 2011 Jul 22.
2
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.家族性低钙血症性高钙血症和原发性甲状旁腺功能亢进症中的血浆25-羟维生素D、1,25-二羟维生素D和甲状旁腺激素
Eur J Endocrinol. 2008 Dec;159(6):719-27. doi: 10.1530/EJE-08-0440. Epub 2008 Sep 11.
3
Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.1型和3型家族性低钙血症性高钙血症与原发性甲状旁腺功能亢进症:异同
J Clin Endocrinol Metab. 2016 May;101(5):2185-95. doi: 10.1210/jc.2015-3442. Epub 2016 Mar 10.
4
Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.高钙血症伴低钙尿症患者中钙敏感受体相关基因突变作为与原发性甲状旁腺功能亢进症的鉴别诊断:在意大利人群中检测到两个新的失活突变
Nephrol Dial Transplant. 2014 Oct;29(10):1902-9. doi: 10.1093/ndt/gfu065. Epub 2014 Aug 7.
5
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.三种肾钙排泄指标对家族性低钙血症性高钙血症和原发性甲状旁腺功能亢进症鉴别的判别能力:方法的随访研究
Clin Endocrinol (Oxf). 2008 Nov;69(5):713-20. doi: 10.1111/j.1365-2265.2008.03259.x. Epub 2008 Apr 10.
6
Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional study.1型家族性低钙血症性高钙血症(FHH)患者小梁骨体积骨密度增加:一项横断面研究。
Calcif Tissue Int. 2014 Aug;95(2):141-52. doi: 10.1007/s00223-014-9877-0. Epub 2014 Jun 4.
7
Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.家族性低钙尿性高钙血症在一个男性索引病例中的表现:在 13 年的临床随访中,与原发性甲状旁腺功能亢进症进行鉴别诊断的灰色地带。
Physiol Res. 2020 Sep 30;69(Suppl 2):S321-S328. doi: 10.33549/physiolres.934522.
8
Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.家族性钙敏感受体异常性甲状旁腺功能亢进症作为一种原发性甲状旁腺功能亢进的非典型形式。
J Bone Miner Res. 2018 Jan;33(1):27-31. doi: 10.1002/jbmr.3339. Epub 2017 Dec 11.
9
A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.一名患有家族性低钙血症性高钙血症和原发性甲状旁腺功能亢进的德国患者中钙敏感受体基因的新型突变。
Hormones (Athens). 2016 Oct;15(4):557-559. doi: 10.14310/horm.2002.1711.
10
Bone mineral density in patients with familial hypocalciuric hypercalcaemia (FHH).
Eur J Surg. 1992 Aug;158(8):397-402.

引用本文的文献

1
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.再探甲状旁腺疾病中的骨:来自流行病学、手术及新药疗效的证据
Endocr Rev. 2025 Jul 15;46(4):576-620. doi: 10.1210/endrev/bnaf010.
2
Bone Disease in Primary Hyperparathyroidism-Changes Occurring in Bone Metabolism and New Potential Treatment Strategies.原发性甲状旁腺功能亢进症中的骨骼疾病——骨骼代谢的变化及新的潜在治疗策略。
Int J Mol Sci. 2024 Oct 30;25(21):11639. doi: 10.3390/ijms252111639.
3
Clinical, Biochemical, and Genetic Profile of an Indian Kindred with Type 1 Familial Hypocalciuric Hypercalcemia.
一个患有1型家族性低钙血症性高钙血症的印度家族的临床、生化和遗传学特征
Indian J Endocrinol Metab. 2021 Sep-Oct;25(5):462-465. doi: 10.4103/ijem.ijem_349_21. Epub 2022 Jan 12.
4
Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.伴有类似家族性低尿钙性高钙血症特征的持续性高钙血症:病例报告及文献复习。
BMC Endocr Disord. 2021 Nov 4;21(1):220. doi: 10.1186/s12902-021-00881-9.
5
Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.家族性低钙尿性高钙血症在一个男性索引病例中的表现:在 13 年的临床随访中,与原发性甲状旁腺功能亢进症进行鉴别诊断的灰色地带。
Physiol Res. 2020 Sep 30;69(Suppl 2):S321-S328. doi: 10.33549/physiolres.934522.
6
Hypercalcemia caused by comorbid parathyroid adenoma and pulmonary tuberculosis.甲状旁腺腺瘤合并肺结核导致高钙血症。
CEN Case Rep. 2021 Feb;10(1):1-5. doi: 10.1007/s13730-020-00509-2. Epub 2020 Jul 6.
7
Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).遗传性甲状旁腺功能亢进症——欧洲内分泌外科医生协会(ESES)共识报告
Langenbecks Arch Surg. 2015 Dec;400(8):867-86. doi: 10.1007/s00423-015-1342-7. Epub 2015 Oct 8.
8
Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.意大利内分泌学会共识声明:轻度原发性甲状旁腺功能亢进症患者的定义、评估与管理
J Endocrinol Invest. 2015 May;38(5):577-93. doi: 10.1007/s40618-015-0261-3. Epub 2015 Mar 28.
9
The calcium-sensing receptor in bone--mechanistic and therapeutic insights.骨钙敏感受体的作用机制及治疗学研究进展
Nat Rev Endocrinol. 2015 May;11(5):298-307. doi: 10.1038/nrendo.2015.30. Epub 2015 Mar 10.
10
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.一项评估钙敏感受体拮抗剂 MK-5442 治疗绝经后骨质疏松症的 2 期、随机、安慰剂对照、剂量范围研究。
J Clin Endocrinol Metab. 2014 Nov;99(11):E2207-15. doi: 10.1210/jc.2013-4009. Epub 2014 Aug 28.